Captor Capital Corp. (CSE:CPTR, FRANKFURT:NMV, STUTTGART:NMVA, USOTC:CPTRF), (“Captor” or the “Company”), an integrated cannabis company, today appointed Bryan Reyhani to the Board of Directors as an Independent Director. Mr. Reyhani has two decades of legal and business experience and has handled various investor, regulatory, financing, and corporate governance matters generally related to a publicly traded company. He replaces Alex Dementev, who has resigned from the Board for health reasons and departs with the Company’s thanks and best wishes.

In 2012, Mr. Reyhani co-founded his own law practice, Reyhani Nemirovsky LLP, where he and the firm handled a wide variety of regulatory matters, litigations and corporate disputes, and developed a specialty practice related to digital assets. In 2017, Mr. Reyhani joined the Eastmore Group as a Managing Director where he was responsible for various legal and business strategies in both the public and private markets.


Prior to co-founding his own law practice, Mr. Reyhani spent approximately nine years at Loeb & Loeb LLP, where he made Partner and was integral to the growth of the Financial Services and Regulatory practice group.  Bryan began his professional career in the Office of General Counsel at Merrill Lynch.

In 2014, Mr. Reyhani also co-founded SolidX Partners, a venture capital-backed startup in the developing digital asset capital markets arena.  In February 2016, he was appointed the Chairman of the Board of Directors of FXCM (n/k/a OTCMKTS: GLBR). In 2018, Mr. Reyhani joined the Board of Directors of Torque Esports Corp. (TSXV: GAME)

Mr. Reyhani graduated from Syracuse University and received his JD from Brooklyn Law School.

About Captor Capital Corp.

Captor Capital Corp. is a Canadian vertically integrated cannabis company listed on the Canadian Securities Exchange, the OTC, and the Frankfurt and Stuttgart stock exchanges. Captor provides recreational and medical marijuana-based products to consumers, as well as other high demand cannabis-based goods for consumption through its network of dispensaries. The Company follows a strategy of acquiring cash flowing established companies and organizations with growth potential that require capital to scale. Captor currently has a number of revenue generating cannabis assets including the CHAI Cannabis Co. dispensaries in Santa Cruz and Monterey, CA. The Company also owns Mellow Extracts, a highly regarded producer of cannabis extracts based in Costa Mesa, CA.

Contact
Gavin Davidson,
Communications
Captor Capital Corp.
647.524.5479
gavin@captorcapital.com

Forward-Looking Statements

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Click here to connect with Captor Capital Corp. (CSE:CPTR, FRANKFURT:NMV, STUTTGART:NMVA, OTC:CPTRF) for an Investor Presentation.

Source

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less